United States (US) Remdesivir Market (2025-2031) | Outlook, Segmentation, Analysis, Value, Competitive Landscape, Forecast, Companies, Share, Trends, Industry, Size & Revenue, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Remdesivir Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Remdesivir Market - Industry Life Cycle

3.4 United States (US) Remdesivir Market - Porter's Five Forces

3.5 United States (US) Remdesivir Market Revenues & Volume Share, By Patient Type, 2021 & 2031F

3.6 United States (US) Remdesivir Market Revenues & Volume Share, By Form, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of infectious diseases, such as COVID-19, driving the demand for remdesivir in the US.

4.2.2 Favorable government initiatives and funding to support research and development of antiviral drugs like remdesivir.

4.2.3 Growing awareness among healthcare professionals about the efficacy of remdesivir in treating viral infections.

4.3 Market Restraints

4.3.1 Stringent regulatory approval processes for new drugs may hinder the market growth of remdesivir in the US.

4.3.2 High cost of remdesivir treatment could limit its accessibility to a larger patient population.

4.3.3 Potential competition from other antiviral drugs or alternative treatment options may pose a challenge to the market expansion of remdesivir.

6.1 United States (US) Remdesivir Market, By Patient Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Remdesivir Market Revenues & Volume, By Patient Type, 2021- 2031F

6.1.3 United States (US) Remdesivir Market Revenues & Volume, By Adult, 2021- 2031F

6.1.4 United States (US) Remdesivir Market Revenues & Volume, By Pediatric, 2021- 2031F

6.1.5 United States (US) Remdesivir Market Revenues & Volume, By Geriatric, 2021- 2031F

6.2 United States (US) Remdesivir Market, By Form

6.2.1 Overview and Analysis

6.2.2 United States (US) Remdesivir Market Revenues & Volume, By Lyophilized Powder, 2021- 2031F

6.2.3 United States (US) Remdesivir Market Revenues & Volume, By Concentrated Solution, 2021- 2031F

7.1 United States (US) Remdesivir Market Export to Major Countries

7.2 United States (US) Remdesivir Market Imports from Major Countries

8.1 Average time taken for regulatory approval of new antiviral drugs in the US.

8.2 Number of clinical trials evaluating the effectiveness of remdesivir in treating different viral infections.

8.3 Rate of adoption of remdesivir in hospitals and healthcare facilities for treating patients with viral illnesses.

9.1 United States (US) Remdesivir Market Opportunity Assessment, By Patient Type, 2021 & 2031F

9.2 United States (US) Remdesivir Market Opportunity Assessment, By Form, 2021 & 2031F

10.1 United States (US) Remdesivir Market Revenue Share, By Companies, 2024

10.2 United States (US) Remdesivir Market Competitive Benchmarking, By Operating and Technical Parameters